Evaluation and Management of Light‑Brown Spotting at 4 Weeks Gestation

Initial Diagnostic Work‑up

Quantitative serum β‑hCG should be obtained immediately as the first step to confirm pregnancy status and provide a baseline for serial monitoring. 1
Transvaginal ultrasound is the preferred initial imaging modality for first‑trimester bleeding, offering superior visualization of early gestational structures (American College of Radiology recommendation). 2
Approximately 25 % of pregnant individuals experience first‑trimester vaginal bleeding of varying severity. 2
Light bleeding or spotting can occur physiologically as the fertilized ovum implants and the cervix becomes hyper‑vascularized. 2

β‑hCG Range	Expected Ultrasound Findings	Clinical Implication
< 1,500 IU/L	Gestational sac often not yet visible.	Serial β‑hCG every 48 h should show a 66‑80 % rise in a viable intrauterine pregnancy; continue monitoring until the discriminatory zone is reached. [1]
1,500‑5,000 IU/L (discriminatory zone)	Gestational sac should be visible on transvaginal scan.	Absence of an intrauterine sac at this level raises concern for ectopic pregnancy or early pregnancy failure. [1]
> 5,000 IU/L	Definitive intrauterine structures (gestational sac, yolk sac, fetal pole) should be apparent.	Confirms intrauterine pregnancy location; manage bleeding accordingly. [1]

Document the presence and location of the gestational sac to differentiate intrauterine from ectopic implantation. 1
Visualize the yolk sac as an early marker of intrauterine gestation. 1
Identify subchorionic hematoma, which may explain early spotting. 1
Evaluate for adnexal masses or free pelvic fluid, which suggest ectopic pregnancy. 1
Light‑brown (old) spotting is less concerning than bright‑red bleeding. (American College of Radiology observation). 2

Refrain from digital pelvic examination until placental location is confirmed by ultrasound to exclude placenta previa. 1

Approximately 95 % of ectopic pregnancies occur in the fallopian tube. 3
Hemodynamic assessment is mandatory; unstable patients need immediate surgical intervention. 1
In hemodynamically stable patients with confirmed ectopic pregnancy, medical management with methotrexate or expectant management may be considered. 1
Methotrexate must not be given unless an ectopic pregnancy is unequivocally diagnosed and an intrauterine pregnancy has been definitively excluded. 1

At 4 weeks gestation, β‑hCG levels and ultrasound findings are more predictive of outcome than symptoms alone. 1
It is often too early at 4 weeks to visualize definitive intrauterine structures; serial β‑hCG combined with ultrasound correlation is essential for accurate diagnosis. 1
Do not rely on a single β‑hCG value or a single ultrasound to determine pregnancy viability. 1

If the initial β‑hCG is below the discriminatory zone, repeat the measurement in 48 hours to assess for an appropriate rise. 1
Perform a repeat transvaginal ultrasound when β‑hCG reaches discriminatory levels or if symptoms worsen. 1